New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in...
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment...